Skip to main content
Skip to main content
TDNT logo

Trident Brands Incorporated (TDNT) Stock Analysis

$0.0003 +$0.00 (+0.00%) |CouncilBearish Lean · 25 · F
Trident Brands Incorporated (TDNT) bottom line: signals are mixed — the Council read leans Bearish Lean (25/100) while the AI fundamental score is 0/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Ken Griffin bearish.
Vol: 2.2K| 52-wk range: $0.0001 – $0.0003
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Trident Brands Incorporated (TDNT) trades at $0.0003. Trident Brands Incorporated focuses on developing and marketing branded consumer products and ingredients within the nutritional supplement, life sciences, and food and beverage sectors across the United States and Canada. Sector: Consumer defensive.

Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026
Trident Brands Incorporated focuses on developing and marketing branded consumer products and ingredients within the nutritional supplement, life sciences, and food and beverage sectors across the United States and Canada. Their portfolio includes DHA supplements under the Brain Armor brand, along with licenses for manufacturing and selling natural health and nutrition products.

Analyst Coverage for TDNT: TDNT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TDNT against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the TDNT film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 25/100 · F

TDNT: 2/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bearish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Trident Brands Incorporated (TDNT) Consumer Business Overview

CEOMichael Jordan Friedman
HeadquartersBrookfield, US
IPO Year2013

Trident Brands Incorporated operates in the consumer defensive sector, focusing on nutritional supplements and functional foods with its Brain Armor DHA supplements. The company navigates a competitive landscape of established packaged food and supplement providers while seeking growth through product innovation and market expansion in the US and Canada.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for TDNT?

As of Mar 16, 2026 — figures reflect the data available on that date.

Trident Brands Incorporated presents a speculative investment opportunity within the consumer defensive sector, specifically in the niche market of DHA supplements. The company's Brain Armor brand targets the growing consumer interest in cognitive health and functional foods. With a negative P/E ratio and a substantial negative profit margin, the company's financial performance requires careful monitoring. Success hinges on effective marketing, strategic partnerships, and successful product innovation. Investors should carefully assess the risks associated with OTC-traded companies and the competitive landscape of the nutritional supplement industry. Key value drivers include revenue growth from Brain Armor sales, expansion into new markets, and efficient management of operating expenses.

Based on FMP financials and quantitative analysis

TDNT Key Highlights

Negative P/E ratio indicates the company is not currently profitable.

  • Profit Margin of -1193.8% reflects significant losses relative to revenue.
  • Gross Margin of 46.1% suggests potential for profitability if operating expenses are managed effectively.
  • Beta of -3.87 indicates the stock is significantly less volatile than the market, but this may be due to its OTC status and limited trading volume.
  • The company focuses on the growing market for DHA supplements under the Brain Armor brand.

Who Are TDNT's Competitors?

TDNT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BRCNF Burcon NutraScience Corporation $1.35 -2.88% $17.1M 59
JVA Coffee Holding Co., Inc. $3.52 +0.57% $20.1M 74
ZHYBF Zhong Yuan Bio-Technology Holdings Limited $2.02 +0.00% $35.8M 64
BUBSF Bubs Australia Limited $0.08 +0.00% $69.2M 53
LFVN LifeVantage Corporation $6.58 +1.31% $83.1M 77
FTLF FitLife Brands, Inc. $10.01 -2.20% $94.0M 59
HBFGF Happy Belly Food Group Inc. $1.23 +3.58% $182M 57
USNA USANA Health Sciences, Inc. $13.18 -0.53% $243M 57

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TDNT's Key Strengths?

Established Brain Armor brand in the DHA supplement market.

  • Licenses for manufacturing, importation, and sale of health products.
  • Focus on the growing market for cognitive health supplements.
  • Proprietary formulations for Brain Armor products.

What Are TDNT's Weaknesses?

Negative profitability and high operating losses.

  • Limited financial resources compared to larger competitors.
  • Reliance on a single brand (Brain Armor).
  • OTC market listing, which can limit investor access and liquidity.

What Could Drive TDNT Stock Higher?

Potential new product launches under the Brain Armor brand targeting specific consumer segments.

  • Expansion of distribution channels through partnerships with retailers and e-commerce platforms.
  • Increasing consumer awareness of the benefits of DHA supplements for cognitive health.
  • Potential strategic acquisitions or partnerships to expand product portfolio and market reach.

What Are the Key Risks for TDNT?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

  • Intense competition from established players in the nutritional supplement industry.
  • Regulatory changes affecting the manufacturing, marketing, and sale of supplements.
  • Negative profitability and high operating losses.
  • Limited financial resources compared to larger competitors.
  • Dependence on the Brain Armor brand for revenue generation.

What Are the Growth Opportunities for TDNT?

  • Expansion of the Brain Armor product line: Trident Brands can capitalize on the growing demand for cognitive health supplements by introducing new Brain Armor products targeting specific age groups or health conditions.
  • Strategic partnerships with retailers: Collaborating with major retailers in the United States and Canada can significantly increase the visibility and accessibility of Brain Armor products. Securing shelf space in established retail chains would provide Trident Brands with a competitive advantage and drive sales growth.
  • E-commerce channel development: Investing in a robust e-commerce platform and digital marketing strategies can enable Trident Brands to reach a wider customer base and enhance brand awareness. The online channel offers opportunities for personalized marketing and direct-to-consumer sales, potentially improving profit margins.
  • Geographic expansion beyond the US and Canada: Exploring opportunities to expand into new international markets with a growing interest in health and wellness products can unlock significant growth potential for Trident Brands. Adapting the Brain Armor product line to meet local regulations and consumer preferences would be crucial for success.
  • Development of new functional food and beverage products: Leveraging its expertise in nutritional supplements, Trident Brands can diversify its product portfolio by developing functional food and beverage products infused with DHA and other beneficial ingredients. This diversification strategy can attract new customers and increase revenue streams.

What Threats Does TDNT Face?

  • Intense competition from established players in the supplement industry.
  • Changing consumer preferences and trends.
  • Regulatory changes affecting the supplement industry.
  • Economic downturns impacting consumer spending on non-essential products.

What Are TDNT's Competitive Advantages?

  • Brand recognition of Brain Armor in the DHA supplement market.
  • Proprietary formulations and intellectual property related to Brain Armor products.
  • Established distribution network within the United States and Canada.
  • Licenses for manufacturing, importation, and sale of natural health and nutrition products.

What Does TDNT Do?

Trident Brands Incorporated, established in 2007 and formerly known as Sandfield Ventures Corp. until its name change in July 2013, is dedicated to the development and marketing of branded consumer products and ingredients. The company operates within the nutritional supplement, life sciences, and food and beverage industries, primarily serving the United States and Canada. Trident Brands' core offering revolves around its Brain Armor brand, a line of DHA supplements designed to support cognitive health. In addition to its branded products, Trident Brands holds banking facilities and licenses that facilitate the manufacturing, importation, and sale of natural health and nutrition products. The company is based in Boca Raton, Florida. Trident Brands aims to establish a strong presence in the functional foods and supplements market by leveraging its Brain Armor brand and strategic partnerships.

What Products and Services Does TDNT Offer?

  • Develops branded consumer products in the nutritional supplement category.
  • Markets and sells DHA supplements under the Brain Armor brand.
  • Focuses on the life sciences and food and beverage sectors.
  • Manufactures, imports, and sells natural health and nutrition products.
  • Operates primarily in the United States and Canada.
  • Holds licenses related to the production and distribution of health products.

How Does TDNT Make Money?

  • Develops and markets branded consumer products.
  • Generates revenue through the sale of nutritional supplements, primarily DHA supplements under the Brain Armor brand.
  • Utilizes licensing agreements for manufacturing and distribution.
  • Focuses on direct sales and retail partnerships to distribute products.

What Industry Does TDNT Operate In?

Trident Brands operates within the consumer defensive sector, specifically in the packaged foods and nutritional supplements industry. This sector is characterized by relatively stable demand, as consumers tend to maintain their spending on essential food and health products even during economic downturns. The nutritional supplement market is experiencing growth, driven by increasing consumer awareness of health and wellness. Trident Brands faces competition from established players in the packaged foods and supplement industries, requiring differentiation through product innovation and effective marketing strategies.

Who Are TDNT's Key Customers?

  • Health-conscious consumers seeking cognitive health benefits.
  • Individuals looking for DHA supplements.
  • Retailers and distributors of health and wellness products.
  • Consumers in the United States and Canada.
AI Confidence: 69% Updated: Mar 16, 2026

Company Profile

Trident Brands Incorporated operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Boca Raton, US. The company is led by CEO Michael Jordan Friedman. TDNT has traded publicly since 2013.

Net selling

Insider Activity

The most recent 9 insider filings for Trident Brands Incorporated break down as 7 sales and 2 purchases. On net that is roughly 38.3M shares disposed (about $866K), a signal worth weighing alongside the fundamentals.

F-Score 2/9

Financial Health

Trident Brands Incorporated's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ROE 9%

Key Financial Metrics

Return on equity for Trident Brands Incorporated stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.11 means current liabilities exceed short-term assets, a liquidity point worth watching.

TDNT Financials

Fundamental Snapshot

Return on Equity (TTM)
+9.1%
Current Ratio
0.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Trident Brands' future prospects, indicating that key stakeholders believe in the company's growth potential.
  • Community sentiment has shifted positively, with discussions highlighting the company's innovative product lines and their appeal to health-conscious consumers.
  • Market perception has improved due to strategic partnerships that enhance distribution channels, making products more accessible to a broader audience.
  • The growing trend towards plant-based products aligns well with Trident's offerings, positioning the company favorably in a rapidly expanding market segment.

Bear Case

  • Some analysts express concern over the company's ability to scale production efficiently, which could hinder growth and market share expansion.
  • Recent social media discussions reveal skepticism about the sustainability of Trident's current market position amid increasing competition in the health food sector.
  • There are worries regarding the company's reliance on a few key products, which could pose risks if consumer preferences shift or if those products underperform.
  • Financial health indicators remain uncertain, and some investors are cautious about potential volatility in a market influenced by broader economic conditions.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

TDNT Latest News

No recent news available for TDNT.

TDNT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TDNT.

Price Targets

Wall Street price target analysis for TDNT.

TDNT MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates TDNT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Michael Jordan Friedman

CEO

Michael Jordan Friedman serves as the CEO of Trident Brands Incorporated. Information regarding his detailed career history, education, and previous roles is not available. As CEO, he is responsible for the overall strategic direction and operational management of the company, including the development, marketing, and sales of the Brain Armor product line and other nutritional supplements.

Track Record: Due to limited information available, it is difficult to assess Michael Jordan Friedman's specific achievements and strategic decisions at Trident Brands. His leadership is focused on growing the Brain Armor brand and expanding the company's presence in the nutritional supplement market. The company's financial performance and market capitalization reflect the challenges and opportunities faced under his leadership.

TDNT OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Trident Brands Incorporated may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, potentially making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.

  • OTC Tier: OTC Other
Liquidity: As an OTC-traded stock, Trident Brands Incorporated likely experiences limited trading volume and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it challenging for investors to buy or sell shares quickly and at desired prices. The illiquidity of OTC stocks can also increase price volatility and the risk of significant losses.
OTC Risk Factors:
  • Limited financial disclosure and transparency.
  • Higher price volatility due to low trading volume.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight compared to major exchanges.
  • Difficulty in obtaining accurate and timely information.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Review the company's OTC Markets profile and disclosure statements.
  • Consult with a qualified financial advisor.
  • Understand the risks associated with investing in OTC stocks.
  • Check for any legal or regulatory issues involving the company.
Legitimacy Signals:
  • Established Brain Armor brand in the DHA supplement market.
  • Licenses for manufacturing, importation, and sale of health products.
  • Focus on the growing market for cognitive health supplements.
  • The company has been in operation since 2007.

TDNT Consumer Defensive Stock FAQ

What does Trident Brands Incorporated do?

Trident Brands Incorporated develops, markets, and sells branded consumer products and ingredients in the nutritional supplement, life sciences, and food and beverage categories. Its primary product is the Brain Armor line of DHA supplements, targeting consumers seeking cognitive health benefits.

What do analysts say about TDNT stock?

As an OTC-traded company with limited analyst coverage, there is no readily available analyst consensus on Trident Brands Incorporated. Investors should conduct their own thorough research and due diligence before making any investment decisions. Key valuation metrics, such as P/E ratio and profit margin, should be carefully evaluated in the context of the company's growth potential and risk factors.

What are the main risks for TDNT?

Trident Brands Incorporated faces several risks, including intense competition from established players in the nutritional supplement industry, regulatory changes affecting the manufacturing and marketing of supplements, and the company's negative profitability and high operating losses. As an OTC-traded company, Trident Brands also faces risks related to limited financial disclosure, lower liquidity, and potential price volatility.

What are the key factors to evaluate for TDNT?

Evaluate TDNT on fundamentals, analyst consensus, and risk factors. Trident Brands Incorporated presents a speculative investment opportunity within the consumer defensive sector, specifically in the niche market of DHA supplements. Not financial advice.

How frequently does TDNT data refresh on this page?

TDNT's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven TDNT's recent stock price performance?

Trident Brands Incorporated (TDNT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established Brain Armor brand in the DHA supplement market. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider TDNT overvalued or undervalued right now?

Trident Brands Incorporated (TDNT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research TDNT before investing?

Before investing in Trident Brands Incorporated (TDNT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on the company's financials and operations.
  • OTC-traded stock with limited liquidity and higher risk.
Data Sources

Popular Stocks

More Stocks We Cover